Dr. Samuel Weiss from the Canadian Institutes of Health Research testified to this committee on December 4 that based on a study they were conducting on 11 safe supply programs, wraparound supports are critical to any purported benefits from the program.
Given that your program offers wraparound supports, how can you credibly claim that a safe supply of hydromorphone is providing any benefits?